Company Filing History:
Years Active: 2000
Title: Paul Laub: Innovator in Peptide Research
Introduction
Paul Laub is a notable inventor based in San Jose, CA (US). He has made significant contributions to the field of peptide research, particularly in the development of compositions that inhibit ribonucleotide reductase enzymes. His work has implications for treating various diseases, including cancer and viral and bacterial infections.
Latest Patents
Paul Laub holds 1 patent for his invention titled "Peptides, peptide analogs, peptidomimetics, and other small molecules." This invention relates to compositions that are useful for inhibiting ribonucleotide reductase enzymes, including the mammalian ribonucleotide reductase enzyme. The compositions include linear peptides, cyclic peptides, peptide analogs, and peptidomimetics. The methods disclosed in this patent provide innovative approaches to treating cancer and infections.
Career Highlights
Paul Laub is affiliated with the University of Pennsylvania, where he continues to advance his research in peptide technology. His work has garnered attention for its potential applications in medical treatments.
Collaborations
Some of his notable coworkers include Barry S. Cooperman and Ralph F. Hirschmann. Their collaborative efforts contribute to the ongoing research and development in the field of peptide-based therapies.
Conclusion
Paul Laub's innovative work in peptide research exemplifies the potential of scientific advancements in medicine. His contributions are paving the way for new treatment options for serious health conditions.